ArticleShock (Augusta, Ga.)2026
Plasma Constituents Promote Endothelial Thromboinflammatory Dysfunction After Hemorrhagic Shock.
Article in Shock (Augusta, Ga.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Rethinking the selection of in vivo thrombosis models in the hybrid era.Nature cardiovascular research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundHemorrhagic shock (HS) following traumatic injury is hallmarked by innate immune activation, hypercoagulability, and thromboinflammatory complications. To date, the direct link between HS, injury severity, and endothelial cell (EC) contributions to thromboinflammation remains poorly understood. The goals of this study were to determine the impact of injury severity and HS on endothelial-mediated thromboinflammation and examine whether these changes increase the propensity for thrombosis.
methodsPlasma from 89 male trauma patients, stratified by HS and injury severity, and 10 healthy subjects were assessed for inflammatory mediators by BioPlex. Human lung microvascular endothelial cells were exposed to patient plasma for 4 hours, after which surface thrombin generation was measured by calibrated automated thrombogram, and ribonucleic acid extracted for gene expression analysis. Plasma from mice that underwent sham or fixed-pressure HS was infused into naive mice, followed by inferior vena cava ligation to induce thrombosis. Thrombi were collected 24 hours later for histologic analysis.
resultsInflammatory mediators were highest in plasma from patients with severe injuries and HS. Human lung microvascular endothelial cells exposed to trauma patient plasma exhibited increased thrombin generation and thromboinflammatory gene expression, with a more pronounced effect in HS patients. Lastly, mice infused with HS plasma developed significantly larger thrombi with higher neutrophil infiltration and reduced EC thrombomodulin expression compared with that of those infused with sham plasma.
conclusionsHS plasma amplifies endothelial-mediated inflammation and coagulation, which is driven, in part, by the presence of inflammatory mediators. HS plasma also increases the development of thrombosis in vivo . This study highlights mechanistic links between ECs, thromboinflammation, and postinjury complications.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.